Institution
Institute for Cardiovascular Diseases of Vojvodina
Recent research
- Health & MedicineOpen access
Background/Objectives: To evaluate the psychometric properties of the MacNew Heart Disease Health-Related Quality of Life Questionnaire (MacNew HRQL) in patients who underwent elective coronary artery bypass grafting (CABG) in Serbia. Methods: Recruitment of participants was orga...
- Health & MedicineOpen access
Introduction: Acute ST-segment elevation myocardial infarction (STEMI) remains a major cause of cardiovascular morbidity and mortality. Despite successful primary percutaneous coronary intervention (pPCI), early myocardial injury and stress may contribute to left ventricular dysf...
- Health & Medicine
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
BackgroundPatients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with minimal bleeding risk. MethodsIn this phase 3, randomized, placebo-con...
- BiologyOpen access
One of the most important adverse consequences of antibiotic use is the development of bacterial resistance. This study investigated the prevalence and antimicrobial resistance patterns of multidrug-resistant (MDR) Escherichia coli in a tertiary care hospital during 2013–2015 and...